%0 Journal Article
%A Jia, Min
%A Zhang, Yan
%A Jansen, Lina
%A Walter, Viola
%A Edelmann, Dominic
%A Gündert, Melanie
%A Tagscherer, Katrin E
%A Roth, Wilfried
%A Bewerunge-Hudler, Melanie
%A Herpel, Esther
%A Kloor, Matthias
%A Ulrich, Alexis
%A Burwinkel, Barbara
%A Bläker, Hendrik
%A Chang-Claude, Jenny
%A Brenner, Hermann
%A Hoffmeister, Michael
%T A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
%J Clinical epigenetics
%V 11
%N 1
%@ 1868-7083
%C [S.l.]
%I BioMed Central
%M DKFZ-2019-01903
%P 109
%D 2019
%X Results of previous studies on the association of the CpG island methylator phenotype (CIMP) with colorectal cancer (CRC) prognosis were inconsistent and mostly based on different CIMP definitions. The current study aimed to comprehensively investigate the associations between DNA methylation on genes previously used to define CIMP status with CRC survival.Patients with CRC followed up for a median of 5.2 years were divided into a study cohort (n = 568) and a validation cohort (n = 308). DNA methylation was measured in tumor tissue using the Illumina Infinium HumanMethylation450 BeadChip and restricted to 43 genes used to define CIMP status in previous studies. Cox proportional hazard regression models were used to estimate adjusted hazard ratios (HR) and 95
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31340858
%2 pmc:PMC6657180
%R 10.1186/s13148-019-0703-4
%U https://inrepo02.dkfz.de/record/144451